Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C P Day

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
Clinical Science (London, England : 1979)|September 1, 1993
Plasma membrane form of phosphatidate phosphohydrolase: a possible role in signal transduction during liver fibrogenesisC P Day, A D Burt, A S Brown, et al.
Gut|July 17, 2001
Association of the tumour necrosis factor alpha -308 but not the interleukin 10 -627 promoter polymorphism with genetic susceptibility to primary sclerosing cholangitisS A Mitchell, J Grove, A Spurkland, et al.
Alimentary Pharmacology & Therapeutics|February 1, 1995
The effect of gastritis on human gastric alcohol dehydrogenase activity and ethanol metabolismA S Brown, J R Fiatarone, P Wood, et al.
Gut|July 14, 2007
The Glasgow alcoholic hepatitis score identifies patients who may benefit from corticosteroidsE H Forrest, A J Morris, S Stewart, et al.
Hepatology (Baltimore, Md.)|November 1, 1991
Investigation of the role of polymorphisms at the alcohol and aldehyde dehydrogenase loci in genetic predisposition to alcohol-related end-organ damageC P Day, R Bashir, O F James, et al.
Cancer Gene Therapy|March 4, 2006
Mutant Bik expression mediated by the enhanced minimal topoisomerase IIalpha promoter selectively suppressed breast tumors in an animal modelC-P Day, K-M Rau, L Qiu, et al.
Journal of Hepatology|March 6, 1999
Tumour necrosis factor-alpha promoter polymorphisms in primary biliary cirrhosisD E Jones, F E Watt, J Grove, et al.
Journal of Hepatology|March 11, 2014
Carriage of the PNPLA3 rs738409 C >G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinomaY-L Liu, G L Patman, J B S Leathart, et al.
Gut|November 22, 2005
Polymorphisms in the T cell regulatory gene cytotoxic T lymphocyte antigen 4 influence the rate of acute rejection after liver transplantationO Tapirdamaz, V Pravica, H J Metselaar, et al.
Gut|July 13, 2005
Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis scoreE H Forrest, C D J Evans, S Stewart, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Clinical Science (London, England : 1979)|September 1, 1993
Plasma membrane form of phosphatidate phosphohydrolase: a possible role in signal transduction during liver fibrogenesisC P Day, A D Burt, A S Brown, et al.
Gut|July 17, 2001
Association of the tumour necrosis factor alpha -308 but not the interleukin 10 -627 promoter polymorphism with genetic susceptibility to primary sclerosing cholangitisS A Mitchell, J Grove, A Spurkland, et al.
Alimentary Pharmacology & Therapeutics|February 1, 1995
The effect of gastritis on human gastric alcohol dehydrogenase activity and ethanol metabolismA S Brown, J R Fiatarone, P Wood, et al.
Gut|July 14, 2007
The Glasgow alcoholic hepatitis score identifies patients who may benefit from corticosteroidsE H Forrest, A J Morris, S Stewart, et al.
Hepatology (Baltimore, Md.)|November 1, 1991
Investigation of the role of polymorphisms at the alcohol and aldehyde dehydrogenase loci in genetic predisposition to alcohol-related end-organ damageC P Day, R Bashir, O F James, et al.
Cancer Gene Therapy|March 4, 2006
Mutant Bik expression mediated by the enhanced minimal topoisomerase IIalpha promoter selectively suppressed breast tumors in an animal modelC-P Day, K-M Rau, L Qiu, et al.
Journal of Hepatology|March 6, 1999
Tumour necrosis factor-alpha promoter polymorphisms in primary biliary cirrhosisD E Jones, F E Watt, J Grove, et al.
Journal of Hepatology|March 11, 2014
Carriage of the PNPLA3 rs738409 C >G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinomaY-L Liu, G L Patman, J B S Leathart, et al.
Gut|November 22, 2005
Polymorphisms in the T cell regulatory gene cytotoxic T lymphocyte antigen 4 influence the rate of acute rejection after liver transplantationO Tapirdamaz, V Pravica, H J Metselaar, et al.
Gut|July 13, 2005
Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis scoreE H Forrest, C D J Evans, S Stewart, et al.
Pageof 9